Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 67

1.

Outcome of Ruptured Abdominal Aortic Aneurysm Repair in Octogenarians: A Systematic Review and Meta-Analysis.

Roosendaal LC, Kramer GM, Wiersema AM, Wisselink W, Jongkind V.

Eur J Vasc Endovasc Surg. 2020 Jan;59(1):16-22. doi: 10.1016/j.ejvs.2019.07.014. Epub 2019 Dec 4. Review.

PMID:
31810836
2.

Sensitivity of 18F-fluorodihydrotestosterone PET-CT to count statistics and reconstruction protocol in metastatic castration-resistant prostate cancer.

Cysouw MCF, Kramer GM, Heijtel D, Schuit RC, Morris MJ, van den Eertwegh AJM, Voortman J, Hoekstra OS, Oprea-Lager DE, Boellaard R.

EJNMMI Res. 2019 Jul 30;9(1):70. doi: 10.1186/s13550-019-0531-8.

3.

Simplified Methods for Quantification of 18F-DCFPyL Uptake in Patients with Prostate Cancer.

Jansen BHE, Yaqub M, Voortman J, Cysouw MCF, Windhorst AD, Schuit RC, Kramer GM, van den Eertwegh AJM, Schwarte LA, Hendrikse NH, Vis AN, van Moorselaar RJA, Hoekstra OS, Boellaard R, Oprea-Lager DE.

J Nucl Med. 2019 Dec;60(12):1730-1735. doi: 10.2967/jnumed.119.227520. Epub 2019 Apr 18.

PMID:
31000583
4.

Assessment of Simplified Methods for Quantification of 18F-FDHT Uptake in Patients with Metastatic Castration-Resistant Prostate Cancer.

Kramer GM, Yaqub M, Vargas HA, Schuit RC, Windhorst AD, van den Eertwegh AJM, van der Veldt AAM, Bergman AM, Burnazi EM, Lewis JS, Chua S, Staton KD, Beattie BJ, Humm JL, Davis ID, Weickhardt AJ, Scott AM, Morris MJ, Hoekstra OS, Lammertsma AA.

J Nucl Med. 2019 Sep;60(9):1221-1227. doi: 10.2967/jnumed.118.220111. Epub 2019 Mar 8.

PMID:
30850488
5.

Repeatability of [18F]FDG PET/CT total metabolic active tumour volume and total tumour burden in NSCLC patients.

Kolinger GD, Vállez García D, Kramer GM, Frings V, Smit EF, de Langen AJ, Dierckx RAJO, Hoekstra OS, Boellaard R.

EJNMMI Res. 2019 Feb 7;9(1):14. doi: 10.1186/s13550-019-0481-1.

6.

Partial-volume correction in dynamic PET-CT: effect on tumor kinetic parameter estimation and validation of simplified metrics.

Cysouw MCF, Golla SVS, Frings V, Smit EF, Hoekstra OS, Kramer GM, Boellaard R; QuIC-ConCePT Consortium.

EJNMMI Res. 2019 Feb 4;9(1):12. doi: 10.1186/s13550-019-0483-z.

7.

Healthy Tissue Uptake of 68Ga-Prostate-Specific Membrane Antigen, 18F-DCFPyL, 18F-Fluoromethylcholine, and 18F-Dihydrotestosterone.

Jansen BHE, Kramer GM, Cysouw MCF, Yaqub MM, de Keizer B, Lavalaye J, Booij J, Vargas HA, Morris MJ, Vis AN, van Moorselaar RJA, Hoekstra OS, Boellaard R, Oprea-Lager DE.

J Nucl Med. 2019 Aug;60(8):1111-1117. doi: 10.2967/jnumed.118.222505. Epub 2019 Jan 10.

PMID:
30630941
8.

Variability and Repeatability of Quantitative Uptake Metrics in 18F-FDG PET/CT of Non-Small Cell Lung Cancer: Impact of Segmentation Method, Uptake Interval, and Reconstruction Protocol.

Zhuang M, García DV, Kramer GM, Frings V, Smit EF, Dierckx R, Hoekstra OS, Boellaard R.

J Nucl Med. 2019 May;60(5):600-607. doi: 10.2967/jnumed.118.216028. Epub 2018 Nov 2.

PMID:
30389824
9.

Molecular Deconvolution Platform to Establish Disease Mechanisms by Surveying GPCR Signaling.

Masuho I, Chavali S, Muntean BS, Skamangas NK, Simonyan K, Patil DN, Kramer GM, Ozelius L, Babu MM, Martemyanov KA.

Cell Rep. 2018 Jul 17;24(3):557-568.e5. doi: 10.1016/j.celrep.2018.06.080.

10.

Performance Evaluation of a Semi-automated Method for [18F]FDG Uptake in Abdominal Visceral Adipose Tissue.

de Boer SA, Spoor DS, Slart RHJA, Mulder DJ, Reijrink M, Borra RJH, Kramer GM, Hoekstra OS, Boellaard R, Greuter MJ.

Mol Imaging Biol. 2019 Feb;21(1):159-167. doi: 10.1007/s11307-018-1211-1.

PMID:
29789994
11.

Reply: Should we assess repeatability of PET quantitative uptake measurements of each 18F-labelled tracer?

Kramer GM, Hoekstra OS, Boellaard R.

Eur J Nucl Med Mol Imaging. 2018 Jul;45(7):1274-1275. doi: 10.1007/s00259-018-4007-2. No abstract available.

PMID:
29654344
12.

Reproducibility and Repeatability of Semiquantitative 18F-Fluorodihydrotestosterone Uptake Metrics in Castration-Resistant Prostate Cancer Metastases: A Prospective Multicenter Study.

Vargas HA, Kramer GM, Scott AM, Weickhardt A, Meier AA, Parada N, Beattie BJ, Humm JL, Staton KD, Zanzonico PB, Lyashchenko SK, Lewis JS, Yaqub M, Sosa RE, van den Eertwegh AJ, Davis ID, Ackermann U, Pathmaraj K, Schuit RC, Windhorst AD, Chua S, Weber WA, Larson SM, Scher HI, Lammertsma AA, Hoekstra OS, Morris MJ.

J Nucl Med. 2018 Oct;59(10):1516-1523. doi: 10.2967/jnumed.117.206490. Epub 2018 Apr 6.

13.

Validation of [18F]FLT as a perfusion-independent imaging biomarker of tumour response in EGFR-mutated NSCLC patients undergoing treatment with an EGFR tyrosine kinase inhibitor.

Iqbal R, Kramer GM, Frings V, Smit EF, Hoekstra OS, Boellaard R; QuIC-ConCePT Consortium.

EJNMMI Res. 2018 Mar 27;8(1):22. doi: 10.1186/s13550-018-0376-6.

14.

Repeatability of quantitative 18F-FLT uptake measurements in solid tumors: an individual patient data multi-center meta-analysis.

Kramer GM, Liu Y, de Langen AJ, Jansma EP, Trigonis I, Asselin MC, Jackson A, Kenny L, Aboagye EO, Hoekstra OS, Boellaard R; QuIC-ConCePT consortium.

Eur J Nucl Med Mol Imaging. 2018 Jun;45(6):951-961. doi: 10.1007/s00259-017-3923-x. Epub 2018 Jan 23.

15.

Impact of partial-volume correction in oncological PET studies: a systematic review and meta-analysis.

Cysouw MCF, Kramer GM, Schoonmade LJ, Boellaard R, de Vet HCW, Hoekstra OS.

Eur J Nucl Med Mol Imaging. 2017 Nov;44(12):2105-2116. doi: 10.1007/s00259-017-3775-4. Epub 2017 Aug 4. Review.

16.

Reply: Repeatability of Quantitative Whole-Body 18F-FDG PET/CT Uptake Measures in Patients with Non-Small Cell Lung Cancer: Dynamic Versus Test-Retest Design.

Kramer GM, Hoekstra OS, Boellaard R.

J Nucl Med. 2017 Sep;58(9):1528-1529. doi: 10.2967/jnumed.117.195461. Epub 2017 Jun 15. No abstract available.

17.

Parametric Method Performance for Dynamic 3'-Deoxy-3'-18F-Fluorothymidine PET/CT in Epidermal Growth Factor Receptor-Mutated Non-Small Cell Lung Carcinoma Patients Before and During Therapy.

Kramer GM, Frings V, Heijtel D, Smit EF, Hoekstra OS, Boellaard R; QuIC-ConCePT Consortium.

J Nucl Med. 2017 Jun;58(6):920-925. doi: 10.2967/jnumed.116.178418. Epub 2016 Nov 10.

18.

Baseline and longitudinal variability of normal tissue uptake values of [18F]-fluorothymidine-PET images.

Cysouw MCF, Kramer GM, Frings V, De Langen AJ, Wondergem MJ, Kenny LM, Aboagye EO, Kobe C, Wolf J, Hoekstra OS, Boellaard R.

Nucl Med Biol. 2017 Aug;51:18-24. doi: 10.1016/j.nucmedbio.2017.05.002. Epub 2017 May 10.

19.

Preclinical Applications of 3'-Deoxy-3'-[18F]Fluorothymidine in Oncology - A Systematic Review.

Schelhaas S, Heinzmann K, Bollineni VR, Kramer GM, Liu Y, Waterton JC, Aboagye EO, Shields AF, Soloviev D, Jacobs AH.

Theranostics. 2017 Jan 1;7(1):40-50. doi: 10.7150/thno.16676. eCollection 2017. Review.

20.

Accuracy and Precision of Partial-Volume Correction in Oncological PET/CT Studies.

Cysouw MCF, Kramer GM, Hoekstra OS, Frings V, de Langen AJ, Smit EF, van den Eertwegh AJ, Oprea-Lager DE, Boellaard R.

J Nucl Med. 2016 Oct;57(10):1642-1649. Epub 2016 May 26.

21.

Repeatability of Quantitative Whole-Body 18F-FDG PET/CT Uptake Measures as Function of Uptake Interval and Lesion Selection in Non-Small Cell Lung Cancer Patients.

Kramer GM, Frings V, Hoetjes N, Hoekstra OS, Smit EF, de Langen AJ, Boellaard R.

J Nucl Med. 2016 Sep;57(9):1343-9. doi: 10.2967/jnumed.115.170225. Epub 2016 Apr 21.

22.

Is ultrasound-guided fine-needle aspiration cytology of adequate value in detecting breast cancer patients with three or more positive axillary lymph nodes?

Kramer GM, Leenders MW, Schijf LJ, Go HL, van der Ploeg T, van den Tol MP, Schreurs WH.

Breast Cancer Res Treat. 2016 Apr;156(2):271-8. doi: 10.1007/s10549-016-3755-6. Epub 2016 Mar 19.

PMID:
26995283
23.

Repeatability of Radiomic Features in Non-Small-Cell Lung Cancer [(18)F]FDG-PET/CT Studies: Impact of Reconstruction and Delineation.

van Velden FH, Kramer GM, Frings V, Nissen IA, Mulder ER, de Langen AJ, Hoekstra OS, Smit EF, Boellaard R.

Mol Imaging Biol. 2016 Oct;18(5):788-95. doi: 10.1007/s11307-016-0940-2.

24.

A systematic review on [(18)F]FLT-PET uptake as a measure of treatment response in cancer patients.

Bollineni VR, Kramer GM, Jansma EP, Liu Y, Oyen WJ.

Eur J Cancer. 2016 Mar;55:81-97. doi: 10.1016/j.ejca.2015.11.018. Epub 2016 Jan 25. Review.

25.

Multiparametric Analysis of the Relationship Between Tumor Hypoxia and Perfusion with ¹⁸F-Fluoroazomycin Arabinoside and ¹⁵O-H₂O PET.

Iqbal R, Kramer GM, Verwer EE, Huisman MC, de Langen AJ, Bahce I, van Velden FH, Windhorst AD, Lammertsma AA, Hoekstra OS, Boellaard R.

J Nucl Med. 2016 Apr;57(4):530-5. doi: 10.2967/jnumed.115.166579. Epub 2015 Dec 10.

26.

Distinct profiles of functional discrimination among G proteins determine the actions of G protein-coupled receptors.

Masuho I, Ostrovskaya O, Kramer GM, Jones CD, Xie K, Martemyanov KA.

Sci Signal. 2015 Dec 1;8(405):ra123. doi: 10.1126/scisignal.aab4068.

27.

Telemental Health for Children and Adolescents: An Overview of Legal, Regulatory, and Risk Management Issues.

Kramer GM, Luxton DD.

J Child Adolesc Psychopharmacol. 2016 Apr;26(3):198-203. doi: 10.1089/cap.2015.0018. Epub 2015 Aug 10. Review.

PMID:
26259027
28.

Evaluating the benefits of a live, simulation-based telebehavioral health training for a deploying army reserve unit.

Mishkind MC, Boyd A, Kramer GM, Ayers T, Miller PA.

Mil Med. 2013 Dec;178(12):1322-7. doi: 10.7205/MILMED-D-13-00278.

PMID:
24306014
29.

ATA practice guidelines for video-based online mental health services.

Turvey C, Coleman M, Dennison O, Drude K, Goldenson M, Hirsch P, Jueneman R, Kramer GM, Luxton DD, Maheu MM, Malik TS, Mishkind MC, Rabinowitz T, Roberts LJ, Sheeran T, Shore JH, Shore P, van Heeswyk F, Wregglesworth B, Yellowlees P, Zucker ML, Krupinski EA, Bernard J.

Telemed J E Health. 2013 Sep;19(9):722-30. doi: 10.1089/tmj.2013.9989. Epub 2013 Aug 3.

PMID:
23909884
30.

CT-perfusion versus [(15)O]H2O PET in lung tumors: effects of CT-perfusion methodology.

Kramer GM, Yaqub M, Bahce I, Smit EF, Lubberink M, Hoekstra OS, Boellaard R.

Med Phys. 2013 May;40(5):052502. doi: 10.1118/1.4798560.

PMID:
23635292
31.

A standard telemental health evaluation model: the time is now.

Kramer GM, Shore JH, Mishkind MC, Friedl KE, Poropatich RK, Gahm GA.

Telemed J E Health. 2012 May;18(4):309-13. doi: 10.1089/tmj.2011.0149. Epub 2012 Mar 16.

PMID:
22424077
32.
33.

The case for ostectomy--a time-tested therapeutic modality in selected periodontitis sites.

Kramer GM.

Int J Periodontics Restorative Dent. 1995 Jun;15(3):228-37.

PMID:
7558656
34.

Defining patient care.

Kramer GM.

Int J Periodontics Restorative Dent. 1995 Feb;15(1):4-5. No abstract available.

PMID:
7591522
35.

Surgical alternatives in regenerative therapy of the periodontium.

Kramer GM.

Int J Periodontics Restorative Dent. 1992;12(1):10-31. Review.

PMID:
1526708
36.

"A rose is a rose is a rose".

Kramer GM.

Int J Periodontics Restorative Dent. 1992;12(2):92-3. No abstract available.

PMID:
1521998
37.

Surgical pocket reduction.

Kramer GM.

J Am Dent Assoc. 1990 Oct;121(4):479-81.

PMID:
2212340
38.

Clinical and histological responses to a mixed bone/hydroxyapatite graft: report of a case.

Kramer GM, Mattout P, Mattout C, Mellonig JT.

Int J Periodontics Restorative Dent. 1989;9(1):8-21. No abstract available.

PMID:
2557292
39.

Periodontics. The unifying force in the practice of dentistry.

Nevins M, Kramer GM.

Dentistry. 1988 Dec;8(4):23-6. No abstract available.

PMID:
3273908
40.

Theory of silicon inversion-layer impurity states derived from constant-energy ellipsoids oriented parallel to the interface.

Kramer GM, Wallis RF.

Phys Rev B Condens Matter. 1988 Jun 15;37(18):10764-10768. No abstract available.

PMID:
9944530
41.

A consideration of root proximity.

Kramer GM.

Int J Periodontics Restorative Dent. 1987;7(6):8-33. No abstract available.

PMID:
3482209
42.

Oxide-charge-induced localized states and screening in a model two-dimensional system.

Glaser E, Czaputa R, McCombe BD, Kramer GM, Wallis RF.

Phys Rev Lett. 1986 Aug 18;57(7):893-896. No abstract available.

PMID:
10034188
43.

The effect of restorative margins on the postsurgical development and nature of the periodontium. Part II. Anatomical considerations.

Pama-Benfenati S, Fugazzotto PA, Ferreira PM, Ruben MP, Kramer GM.

Int J Periodontics Restorative Dent. 1986;6(1):64-75. No abstract available.

PMID:
3457774
44.

Theory of impurity-band conduction in silicon inversion layers in high magnetic fields.

Kramer GM, Wallis RF.

Phys Rev B Condens Matter. 1985 Sep 15;32(6):3772-3779. No abstract available.

PMID:
9937527
45.

[Mineral metabolism of bones in osteomyelitis].

Sveshnikov AA, Ofitserova NV, Kramer GM.

Patol Fiziol Eksp Ter. 1984 Jul-Aug;(4):63-5. Russian. No abstract available.

PMID:
6483483
46.

The influence of prosthetic stem stiffness and of a calcar collar on stresses in the proximal end of the femur with a cemented femoral component.

Lewis JL, Askew MJ, Wixson RL, Kramer GM, Tarr RR.

J Bone Joint Surg Am. 1984 Feb;66(2):280-6.

PMID:
6693456
47.

[Nuclear medical diagnosis in the treatment of Ilizarov's posttraumatic osteomyelitis].

Svesnikov AA, Kramer GM, Smotrova LA, Mingazova NB.

Radiol Diagn (Berl). 1984;25(5):587-94. German. No abstract available.

PMID:
6095364
48.

Predetermination of osseous changes associated with uprighting tipped molars by probing.

Wise RJ, Kramer GM.

Int J Periodontics Restorative Dent. 1983;3(1):68-81. No abstract available.

PMID:
6574119
49.

Clinical application and histologic evaluation of microfibrillar collagen hemostat (Avitene) in periodontal surgery.

Kramer GM, Pollack R.

Int J Periodontics Restorative Dent. 1982;2(1):8-16. No abstract available.

PMID:
6959975
50.

[Pathogenetic characteristics of experimental traumatic osteomyelitis (immunological and bacteriological aspects)].

Veselov AIa, Kramer GM, Chudner VZ.

Zh Mikrobiol Epidemiol Immunobiol. 1980 Sep;(9):52-7. Russian.

PMID:
7445880

Supplemental Content

Loading ...
Support Center